Old Web
English
Sign In
Acemap
>
authorDetail
>
Stacie Richardson
Stacie Richardson
Cornell University
Medicine
Histone deacetylase inhibitor
Chemotherapy
Pemetrexed
Histone deacetylase
4
Papers
1103
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KRAS mutations and outcomes for patients with stage IV NSCLC treated with frontline platinum/pemetrexed based chemotherapy.
2012
Journal of Clinical Oncology
Benjamin Levy
Nagashree Seetharamu
Stacie Richardson
Daniel Jacob Becker
Walter Choi
Andrew Evans
Faiz Y. Bhora
Cliff P. Connery
Michael L. Grossbard
Abraham Chachoua
Show All
Source
Cite
Save
Citations (3)
Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Patients With Advanced Hematologic Malignancies
2006
Journal of Clinical Oncology
Owen A. OConnor
Mark L. Heaney
Lawrence H. Schwartz
Stacie Richardson
Robert D. Willim
Barbara MacGregor-Cortelli
Tracey Curly
Craig H. Moskowitz
Carol S. Portlock
Steven M. Horwitz
Andrew D. Zelenetz
Stanley R. Frankel
Victoria M. Richon
Paul A. Marks
William Kevin Kelly
Show All
Source
Cite
Save
Citations (387)
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
2003
Clinical Cancer Research
Kelly Wk
Victoria M. Richon
Owen A. OConnor
Tracy Curley
Barbara MacGregor-Curtelli
William P. Tong
Mark Klang
Lawrence H. Schwartz
Stacie Richardson
Eddie Rosa
Marija Drobnjak
Carlos Cordon-Cordo
Judy H. Chiao
R A Rifkind
Paul A. Marks
Howard I. Scher
Show All
Source
Cite
Save
Citations (599)
1